ACADIA Pharmaceuticals Inc.

(ACAD) Trade

By |

Profile

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Contact Information

Website: www.acadia-pharm.com
Email: ir@acadia-pharm.com
Main Phone: +1 858 558-2871
Address: 3611 Valley Centre Drive
Address 2: Suite 300
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92130

Issuer Information

Exchange: NGS
CEO: Stephen R. Davis
Employees: 550
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More

Profile

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Contact Information

Website: www.acadia-pharm.com
Email: ir@acadia-pharm.com
Main Phone: +1 858 558-2871
Address: 3611 Valley Centre Drive
Address 2: Suite 300
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92130

Issuer Information

Exchange: NGS
CEO: Stephen R. Davis
Employees: 550
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
$ 51.61 $ 1.32 (2.62%)
Last Price 51.61 Change $ 1.32 Change % 2.62 Tick N/A
Bid 51.07 Bid Size 1,900.00 Ask 51.90 Ask Size 100.00
Open 50.91 High 52.28 Low 50.31 Prev Close 50.29
Last Trade Volume 1.1 mi 52 Wk Hi 53.75 52 Wk Low 21.56
Market Cap 8 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 155,861,373.00 EPS (TTM) -1.58 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 27
Number of Buys 0 19
Number of Sells 0 8
Net Activity 0 12121
Last 10 Buys Shares
Daniel B. Soland 1,000
Daniel B. Soland 1,000
Daniel B. Soland 1,000
Daniel B. Soland 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Last 10 Sell Shares
Glenn F. Baity 1,000
Laura Brege 1,000
Glenn F. Baity 1,000
Glenn F. Baity 1,000
Glenn F. Baity 1,000
Glenn F. Baity 1,000
Glenn F. Baity 1,000
Glenn F. Baity 1,000
Terrence O. Moore 1,000
Terrence O. Moore 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 61 61 61 61
Low Target Price Estimate 41 41 41 41
Mean Target Price Estimate 52.4 52.4 51.5 52.4
Standard Deviation 8.26 8.26 7.71 8.26
Date of Most Recent Estimate 05/07/18 05/07/18 05/07/18 05/07/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 6 6
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1